A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04072354 |
|
Recruitment Status :
Completed
First Posted : August 28, 2019
Last Update Posted : May 8, 2024
|
Sponsor:
Sumitomo Pharma America, Inc.
Information provided by (Responsible Party):
Sumitomo Pharma America, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 12, 2023 |
| Actual Study Completion Date : | September 12, 2023 |
| Certification/Extension First Submitted : | May 6, 2024 |